Achieve Life Sciences, Inc. (ACHV)
7.84
-0.65
(-7.66%)
USD |
NASDAQ |
Sep 08, 16:00
7.90
+0.06
(+0.77%)
Pre-Market: 08:37
Achieve Life Sciences Total Liabilities (Quarterly) : 205.12M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 205.12M |
| March 31, 2026 | 22.43M |
| December 31, 2025 | 20.56M |
| September 30, 2025 | 18.42M |
| June 30, 2025 | 17.27M |
| March 31, 2025 | 17.08M |
| December 31, 2024 | 17.73M |
| September 30, 2024 | 16.54M |
| June 30, 2024 | 22.51M |
| March 31, 2024 | 20.57M |
| December 31, 2023 | 20.82M |
| September 30, 2023 | 20.30M |
| June 30, 2023 | 19.22M |
| March 31, 2023 | 20.36M |
| December 31, 2022 | 21.67M |
| September 30, 2022 | 22.68M |
| June 30, 2022 | 20.82M |
| March 31, 2022 | 19.18M |
| December 31, 2021 | 19.47M |
| September 30, 2021 | 3.099M |
| June 30, 2021 | 4.711M |
| March 31, 2021 | 3.574M |
| December 31, 2020 | 3.012M |
| September 30, 2020 | 1.942M |
| June 30, 2020 | 1.92M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.662M |
| December 31, 2019 | 3.028M |
| September 30, 2019 | 3.351M |
| June 30, 2019 | 3.251M |
| March 31, 2019 | 4.312M |
| December 31, 2018 | 3.282M |
| September 30, 2018 | 2.977M |
| June 30, 2018 | 2.778M |
| March 31, 2018 | 2.318M |
| December 31, 2017 | 2.013M |
| September 30, 2017 | 2.347M |
| June 30, 2017 | 1.775M |
| March 31, 2017 | 2.012M |
| December 31, 2016 | 8.504M |
| September 30, 2016 | 10.66M |
| June 30, 2016 | 13.95M |
| March 31, 2016 | 14.62M |
| December 31, 2015 | 20.77M |
| September 30, 2015 | 29.46M |
| June 30, 2015 | 35.16M |
| March 31, 2015 | 16.36M |
| December 31, 2014 | 22.23M |
| September 30, 2014 | 23.80M |
| June 30, 2014 | 23.27M |
| March 31, 2014 | 20.22M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 46.19M |
| Perspective Therapeutics, Inc. | 68.16M |
| MiMedx Group, Inc. | 65.00M |
| ProText Mobility, Inc. | 0.1916M |
| ABVC BioPharma, Inc. | 7.131M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 190.44M |
| Shareholders Equity (Quarterly) | -14.68M |
| Debt to Equity Ratio | -1.018 |
| Current Ratio | 0.9526 |
| Net Debt Paydown Yield | -0.15% |